Stromal cell heterogeneity in fibroblast growth factor-mediated stromal-epithelial cell cross-talk in premalignant prostate tumors

Cancer Research

Volumn 63, Issue 16, 2003, Pages 4936-4944

  Wu, Xiaochong ^a,b,c   Jin, Chengliu ^a   Wang, Fen ^a   Yu, Chundong ^a,b,d   McKeehan, Wallace L ^a  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; DNA; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR RECEPTOR; KERATIN; MESSENGER RNA; THYMIDINE; TRITIUM; VIMENTIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CLONE; CELL CULTURE; CONTROLLED STUDY; DNA SYNTHESIS; EPITHELIUM CELL; GENE EXPRESSION; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; ISOTOPE LABELING; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE TUMOR; RAT; RECEPTOR BINDING; STROMA CELL;

ADENOCARCINOMA; CELL COMMUNICATION; CELL DIVISION; DNA; EPITHELIAL CELLS; FIBROBLAST GROWTH FACTOR 7; FIBROBLAST GROWTH FACTOR 9; FIBROBLAST GROWTH FACTORS; HOMEOSTASIS; HUMANS; MALE; PRECANCEROUS CONDITIONS; PROSTATIC NEOPLASMS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; RECEPTORS, FIBROBLAST GROWTH FACTOR; RNA, MESSENGER; STROMAL CELLS; TUMOR CELLS, CULTURED;

EID: 0042941495     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Hayward, S. W., Rosen, M. A., and Cunha, G. R. Stromal-epithelial interactions in the normal and neoplastic prostate. Br. J. Urol., 79 (Suppl. 2): 18-26, 1997.
2. Cunha, G. R. Epithelio-mesenchymal interactions in primordial gland structures which become responsive to androgenic stimulation. Anat. Rec., 172: 179-195, 1972.
3. Cunha, G. R., Shannon, J. M., Taguchi, O., Fujii, H., and Chung, L. W. Mesenchymal-epithelial interactions in hormone-induced development. J. Anim. Sci., 55 (Suppl. 2): 14-31, 1982.
4. Cunha, G. R., Fujii, H., Neubauer, B. L., Shannon, J. M., Sawyer, L., and Reese, B. A. Epithelial-mesenchymal interactions in prostatic development. I. morphological observations of prostatic induction by urogenital sinus mesenchyme in epithelium of the adult rodent urinary bladder. J. Cell Biol., 96: 1662-1670, 1983.
5. Cunha, G. R., and Donjacour, A. Stromal-epithelial interactions in normal and abnormal prostatic development. Prog. Clin. Biol. Res., 239: 251-272, 1987.
6. Matrisian, L. M., Cunha, G. R., and Mohla, S. Epithelial-stromal interactions and tumor progression: meeting summary and future directions. Cancer Res., 61: 3844-3846, 2001.
7. Wong, Y. C., and Wang, Y. Z. Growth factors and epithelial-stromal interactions in prostate cancer development. Int. Rev. Cytol., 199: 65-116, 2000.
8. Yan, G., Fukabori, Y., McBride, G., Nikolaropoulos, S., and McKeehan, W. L. Exon switching and activation of stromal and embryonic fibroblast growth factor (FGF)-FGF receptor genes in prostate epithelial cells accompany stromal independence and malignancy. Mol. Cell. Biol., 13: 4513-4522, 1993.
9. Wu, X., Kan, M., Wang, F., Jin, C., Yu, C., and McKeehan, W. L. A rare premalignant prostate tumor epithelial cell syndecan-1 forms a fibroblast growth factor-binding complex with progression-promoting ectopic fibroblast growth factor receptor 1. Cancer Res., 61: 5295-5302, 2001.
10. Wang, F., McKeehan, K., Yu, C., and McKeehan, W. L. Fibroblast growth factor receptor 1 phosphotyrosine 766: molecular target for prevention of progression of prostate tumors to malignancy. Cancer Res., 62: 1898-1903, 2002.
11. Feng, S., Wang, F., Matsubara, A., Kan, M., and McKeehan, W. L. Fibroblast growth factor receptor 2 limits and receptor 1 accelerates tumorigenicity of prostate epithelial cells. Cancer Res., 57: 5369-5378, 1997.
12. Tennant, T. R., Kim, H., Sokoloff, M., and Rinker-Schaeffer, C. W. The Dunning model. Prostate, 43: 295-302, 2000.
13. McKeehan, W. L., Adams, P. S., and Fast, D. Different hormonal requirements for androgen-independent growth of normal and tumor epithelial cells from rat prostate. In Vitro Cell. Dev. Biol.-Animal, 23: 147-152, 1987.
14. Mansson, P. E., Adams, P., Kan, M., and McKeehan, W. L. Heparin-binding growth factor gene expression and receptor characteristics in normal rat prostate and two transplantable rat prostate tumors. Cancer Res., 49: 2485-2494, 1989.
15. Isaacs, J. T. Development and characteristics of the available animal model systems for the study of prostatic cancer. Prog. Clin. Biol. Res., 239: 513-576, 1987.
16. Kan, M., Wu, X., Uematsu, F., and Wang, F. Directional specificity of prostate stromal to epithelial cell communication via FGF7/FGFR2 is set by cell- and FGFR2 isoform-specific heparan sulfate. In Vitro Cell. Dev. Biol.-Animal, 37: 575-577, 2001.
17. McKeehan, W. L., Wang, F., and Kan, M. The heparan sulfate-fibroblast growth factor family: diversity of structure and function. Prog. Nucleic Acid Res. Mol. Biol., 59: 135-176, 1998.
18. Yan, G., Fukabori, Y., Nikolaropoulos, S., Wang, F., and McKeehan, W. L. Heparin-binding keratinocyte growth factor is a candidate stromal-to-epithelial-cell andromedin. Mol. Endocrinol., 6: 2123-2128, 1992.
19. Naimi, B., Latil, A., Fournier, G., Mangin, P., Cussenot, O., and Berthon, P. Down-regulation of (IIIb) and (IIIc) isoforms of fibroblast growth factor receptor 2 (FGFR2) in human prostate. Prostate, 52: 245-252, 2002.
20. Ricol, D., Cappellen, D., El Marjou, A., Gil-Diez-de-Medina, S., Girault, J. M., Yoshida, T., Ferry, G., Tucker, G., Poupon, M. F., Chopin, D., Thiery, J. P., and Radvanyi, F. Tumour suppressive properties of fibroblast growth factor receptor 2-IIIb in human bladder cancer. Oncogene, 18: 7234-7243, 1999.
21. Zhang, Y., Wang, H., Ratani, S., Sato, J. D., Kan, M., McKeehan, W. L., and Okamoto, T. Growth inhibition by keratinocyte growth factor receptor of human salivary adenocarcinoma cells through induction of differentiation and apoptosis. Proc. Natl. Acad. Sci. U S A, 98: 11336-1340, 2001.
22. Matsubara, A., Kan, M. Feng, S., and McKeehan, W. L. Inhibition of growth of malignant rat prostate tumor cells by restoration of fibroblast growth factor receptor 2. Cancer Res., 58: 1509-1514, 1998.
23. Lu, W., Luo, Y., Kan, M., and McKeehan, W. L. Fibroblast growth factor-10. A second candidate stromal to epithelial cell andromedin in prostate. J. Biol. Chem., 274: 12827-12834, 1999.
24. Jones, R. B., Wang, F., Luo, Y., Yu, C., Jin, C., Suzuki, T., Kan, M., and McKeehan, W. L. The nonsense-mediated decay pathway and mutually exclusive expression of alternatively spliced FGFR2IIIb and IIIc mRNAs. J. Biol. Chem., 276: 4158-4167, 2001.
25. Ye, S., Luo, Y., Lu, W., Jones, R. B., Linhardt, R. J., Capila, I., Toida, L., Kan, M., Pelletier, H., and McKeehan, W. L. Structural basis for interaction of FGF-1, FGF-2 and FGF-7 with different heparan sulfate motifs. Biochemistry, 40: 14429-14439, 2001.
26. Kan, M., Shi, E. G., and McKeehan, W. L. Identification and assay of fibroblast growth factor receptors. Methods Enzymol., 198: 158-171, 1991.
27. Luo, Y., Lu, W., Mohamedali, K., Jang, J-H., Jones, R. B., Gabriel, J. L., Kan, M., and McKeehan, W. L. The glycine box: A determinant of specificity for fibroblast growth factor. Biochemistry, 37: 16506-16515, 1998.
28. Cunha, G. R., Hayward, S. W., Dahiya, R., and Foster, B. A. Smooth muscle-epithelial interactions in normal and neoplastic prostatic development. Acta Anat., 155: 63-72, 1996.
29. Powell, D. W., Mifflin, R. C., Valentich, J. D., Crowe, S. E., Saada, J. I., and West, A. B. Myofibroblasts. I. Paracrine cells important in health and disease. Am. J. Physiol., 277 (Cell Physiol. 46): C1-C19, 1999.
30. Tuxhorn, J. A., Ayala, G. E., and Rowley, D. R. Reactive stroma in prostate cancer progression. J. Urol., 166: 2472-2483, 2001.
31. Guo, L., Degenstein, L., and Fuchs, E. Keratinocyte growth factor is required for hair development but not for wound healing. Genes Dev., 10: 165-175, 1996.
32. Ohuchi, H., Hori, Y., Yamasaki, M., Harada, H., Sekine, K., Kato, S., and Itoh, N. FGF10 acts as a major ligand for FGF receptor 2 IIIb in mouse multi-organ development. Biochem. Biophys. Res. Commun., 277: 643-649, 2000.
33. Thomson, A. A. Role of androgens and fibroblast growth factors in prostatic development. Reproduction, 121: 187-195, 2001.
34. Thomson, A. A., and Cunha, G. R. Prostatic growth and development are regulated by FGF10. Development, 126: 3693-3701, 1999.
35. Ropiquet, F., Giri, D., Kwabi-Addo, B., Schmidt, K., and Ittmann, M. FGF-10 is expressed at low levels in the human prostate. Prostate, 44: 334-338, 2000.
36. Uematsu, F., Kan, M., Wang, F., Jang, J. H., Luo, Y., and McKeehan, W. L. Ligand binding properties of binary complexes of heparin and immunoglobulin-like modules of FGF receptor 2. Biochem. Biophys. Res. Commun., 272: 830-836, 2000.
37. Ronnov-Jessen, L., and Petersen, O. W. Induction of α-smooth muscle actin by transforming growth factor-β 1 in quiescent human breast gland fibroblasts. Implications for myofibroblast generation in breast neoplasia. Lab. Investig., 68: 696-707, 1993.
38. Maltseva, O., Folger, P., Zekaria, D., and Petridou, S. Masur, S. K. Fibroblast growth factor reversal of the corneal myofibroblast phenotype. Investig. Ophthalmol. Vis. Sci., 42: 2490-2495, 2001.
39. Camps, J. L., Chang, S. M., Hsu, T. C., Freeman, M. R., Hong, S. J., Zhau, H. E., von Eschenbach, A. C., and Chung, L. W. Fibroblast-mediated acceleration of human epithelial tumor growth in vivo. Proc. Natl. Acad. Sci. USA, 87: 75-79, 1990.
40. Chung, L. W. The role of stromal-epithelial interaction in normal and malignant growth. Cancer Surv., 23: 33-42, 1995.
41. Olumi, A. F., Grossfeld, G. D., Hayward, S. W., Carroll, P. R., Tlsty, T. D., and Cunha, G. R. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res., 59: 5002-5011, 1999.
42. Salm, S. N., Takao, T., Tsujimura, A., Coetzee, S., Moscatelli, D., and Wilson, E. L. Differentiation and stromal-induced growth promotion of murine prostatic tumors. Prostate, 51: 175-188, 2002.
43. Xu, J., Nakahara, M., Crabb, J. W., Shi, E., Matuo, Y., Fraser, M., Kan, M., Hou, J., and McKeehan, W. L. Expression and immunochemical analysis of rat prostate and human heparin-binding fibroblast growth factor receptor (flg) isoforms. J. Biol. Chem., 267: 17792-17803, 1992.